Stock screenerAll disclosures →
EDGAR →
COLL
Conviction 27HealthcareScan · Thu, Jun 25, 2026Bearish engulfing
COLL$34.85-2.05%
ResistanceSupportVol 14Insider sellVol MA14 383.01K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price34.85
Change-2.05%
Gap+0.42%
Rel volume1.11×
Avg volume408.1K
Avg $ vol13.63M
SMA 2033.62
SMA 5034.07
SMA 20039.22
Price vs 50+2.29%
Price vs 200-11.15%
MA stackmixed
50/200 cross—
Supertrendup · 31.38
RSI (14)54
MACD hist0.20
MACD cross—
Stoch %K / %D72 / 81
ADX (14)13
+DI / −DI27 / 21
RSI divergence—
MACD divergence—
ATR %+3.96%
ADR %3.73%
52w high49.84
52w low29.57
From 52w high-30.08%
Above 52w low+17.86%
New 52w highNo
SqueezeOff
Bollinger width15.11%
%B0.74
Donchian pos79.19%
Donchian high36.09
Donchian low30.13
AVWAP (52w high)38.30
vs AVWAP high-9.02%
AVWAP (52w low)39.20
vs AVWAP low-11.10%
OBV trendDown
Chaikin MF (20)-0.10
Today vs 20d1.11×
Avg vol (14d)383.01K
Avg vol (20d)408.1K
Avg $ vol (20d)13.63M
Market cap1.13B
RS 3m (vs SPY)-5.19%
RS 6m (vs SPY)-34.95%
RS line new highNo
Trend template2/8
Technical rank39.9
1 week+3.47%
1 month+3.17%
3 months+4.81%
6 months-28.64%
1 year+15.74%
YTD-23.46%
P/E17.98
P/B3.62
P/S1.45
P/FCF3.45
EPS1.73
Div yield—
ROE20.12%
ROA3.81%
Debt/Eq0.05
Current1.71
EV/EBITDA4.86
Gross margin59.35%
Net margin8.05%
Rev growth23.62%
EPS growth-9.13%
Price target54.00
Target upside54.95%
Analyst ratingBuy
Institutional125.09%
Ent. value875.84M
Revenue193.52M
Net income14.5M
Gross profit117.25M
Free cash flow327.58M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out32.43M
Employees423
ListedThu, May 7, 2015
Free float30.41M
Float %93.8%
Short interest5.66M
Days to cover17.8d
Short volume74.6%
Squeeze score84 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast$1.48 · 2 est
Last EPS vs est$1.50 vs $1.23
Last surprise+21.9% beat
Setup gradeD
Conviction27 / 100
Pattern quality—
Tech rank39.9 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBearish engulfing
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in COLL
No recent disclosed trades by Congress in COLL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in COLL · 4 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
SANTINI GINO Director · Stock Option (Right to Purchase) · 2026-06-08 | Exercise | 8.7K | $0 | 2026-06-08 | 2026-06-10 |
SANTINI GINO Director · Common Stock · 2026-06-08 | Exercise | 8.7K | $143K | 2026-06-08 | 2026-06-10 |
Freund John Gordon Director · Common Stock · 2026-05-18 | Other | — | — | 2026-05-18 | 2026-05-20 |
Freund John Gordon Director · Common Stock · 2026-05-18 | Sell | 20 | $681 | 2026-05-18 | 2026-05-20 |
Freund John Gordon Director · Common Stock · 2026-05-15 | Exercise | 8.7K | $143K | 2026-05-15 | 2026-05-18 |
Freund John Gordon Director · Stock Option (Right to Purchase) · 2026-05-15 | Exercise | 8.7K | $0 | 2026-05-15 | 2026-05-18 |
Freund John Gordon Director · Common Stock · 2026-05-15 | Sell | 4.13K | $143K | 2026-05-15 | 2026-05-18 |
Balice-Gordon Rita J. Director · Common Stock · 2026-05-14 | Grant | 8.74K | $0 | 2026-05-14 | 2026-05-18 |
SANTINI GINO Director · Common Stock · 2026-05-14 | Grant | 8.74K | $0 | 2026-05-14 | 2026-05-18 |
Freund John Gordon Director · Common Stock · 2026-05-14 | Other | — | — | 2026-05-14 | 2026-05-18 |
SEC filings
EDGAR filings in COLL
No recent SEC filings on file for COLL.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.